Help "intervention without implantation" and lead patients with coronary heart disease to regain the "heart" life

In the field of interventional treatment of coronary heart disease, cutting balloons is a special class of balloons, which is a new technology that combines micro-cutting techniques with traditional balloon dilation. However, high technical barriers allow foreign products to monopolize the market for a time, at the end of 2020, Lepu Medical's Vesscide cutting balloon system was officially listed, completely breaking the monopoly situation of foreign enterprises, filling the gap of similar domestic products in mainland China, and the advent of domestic cutting balloon system provided patients with advanced technology and high-quality coronary intervention treatment programs for coronary heart disease patients, while promoting the "intervention without implantation" treatment of coronary heart disease in mainland China to a new level.

It was learned from a tertiary hospital in Shanxi Province that not long ago, the hospital successfully completed a surgery in which a cutting balloon and NeoVas bioresorbable stent were combined to treat patients with coronary heart disease. The patient recently developed post-activity chest pain, chest tightness and other symptoms, and after going to the hospital for examination, it was found that there was a narrowing of coronary blood vessels, and the stenosis rate of one section was as high as 80%, which required stent implantation for treatment. However, the patient is only a young man in his 40s, worried about the lifelong implantation of traditional metal stents, after the analysis of the condition and communication with the patient, the doctor finally selected a combination of Vesscide cutting balloon and NeoVas bioresorbable stent for the patient, after the operation, the patient's chest pain and other symptoms disappeared and received a good treatment effect.

Vesscide Cutting Balloon: Cuts plaque, defends against vascular elastic retraction, and enhances the effectiveness of interventional treatment for coronary heart disease

It is understood that the two innovative products used in this operation are developed by Lepu Medical, a leading company in mainland interventional instruments, of which the Vestscide cutting balloon is currently the only domestic product of its kind listed. The balloon is equipped with a 3-4 column microscopic blade longitudinally on the surface to cut plaque and expand the blood vessel wall, ultimately benefiting the vascular lumen. When the balloon is delivered to the lesion, as the balloon is pressurized to expand, the microscopic blade on the balloon gradually extends out of the balloon surface, and then achieves the effect of treating or adequately pretreating the diseased blood vessels by cutting plaques and expanding blood vessels.

Lepu's cut balloon is suitable for all ordinary balloons can treat coronary atherosclerotic lesions, in mild to moderate calcification lesions, mouth and bifurcation lesions, stent restenosis, small vascular lesions more obvious advantages, while cutting balloons can not only be used as a therapeutic device alone, but also can be used in combination with metal stents, drug balloons, bioabsorbable stents and other instruments, significantly optimizing its therapeutic effect.

The long-term benefits of "intervention without implantation" patients are revealed, and a variety of innovative products help patients recover their health

In recent years, with the promotion of the concept of "intervention without implantation" in coronary heart disease and the increasingly rich experience in clinical application, the long-term benefits of patients brought by innovative products have gradually emerged, making them more concerned by doctors and patients. At present, Lepu Medical has laid out NeoVas bioresorbable stents, Vesselin coronary drug balloon and Vescide cutting balloon in this field, three new products with the concept of "intervention without implantation", which can rely on their different advantages to provide more accurate and rich surgical treatment programs for patients with coronary heart disease and clinicians. It is believed that in the near future, with the development of science and technology and the continuous exploration of enterprises, more innovative medical devices will come out, benefiting more patients with coronary heart disease and building a stronger barrier for protecting the health of the "heart".

[ Editor-in-Charge: Ran Li ]

【Source: Guangming Network】